Dr. Torsten Neuefeind, CEO Proteros

“I am impressed by Bioscience Valuation’s very profound, analytical approach to evaluate early discovery projects. Bioscience Valuation substantially supported us in successful partnering negotiations, and it is a continuous pleasure to work with Joachim and his team.”